Accounts of Chemical Research
[ASAP] Nanoparticles and Nanocolloidal Carbon: Will They Be the Next Antidiabetic Class That Targets Fibrillation and Aggregation of Human Islet Amyloid Polypeptide in Type 2 Diabetes?
Accounts of Chemical ResearchDOI: 10.1021/acs.accounts.2c00415